Recordati reported EUR643.15M in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Almirall EUR 275M 9.6M Jun/2025
GlaxoSmithKline GBP 7.99B 470M Jun/2025
Hikma Pharmaceutical USD 1.59B 18M Dec/2024
Orion EUR 416.5M 61.9M Jun/2025
Sanofi EUR 9.99B 90M Jun/2025